Prognostic significance of pan-immune-inflammatory value in adverse cardiovascular and cerebrovascular events post-percutaneous coronary intervention in diabetic patients with coronary heart disease - Takeaways - MDSpire

Prognostic significance of pan-immune-inflammatory value in adverse cardiovascular and cerebrovascular events post-percutaneous coronary intervention in diabetic patients with coronary heart disease

  • By

  • Qinghong Liu

  • Mao Tian

  • Jiangjun Guo

  • Wenhao Chen

  • Wenting Wu

  • Huadong Yu

  • Bo Zhu

  • July 7, 2026

  • 0 min

Share

  • 1

    The pan-immune-inflammatory value (PIV) is a novel biomarker reflecting systemic inflammation in diabetic patients with coronary heart disease.

  • 2

    High pre-procedural PIV is linked to an increased risk of major adverse cardiovascular and cerebrovascular events after percutaneous coronary intervention.

  • 3

    PIV demonstrated superior prognostic performance compared to conventional inflammatory indices like SII, NLR, and PLR.

  • 4

    Patients with high PIV experienced poorer long-term MACCE-free survival following coronary intervention.

  • 5

    PIV may serve as a cost-effective biomarker for individualized risk stratification in diabetic patients undergoing PCI.

Original Source(s)

Related Content